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Rapport de synthèse 
La consommation de boissons sucrées contenant du fructose a remarquablement augmenté ces 
dernières décennies et, on pense qu'elle joue un rôle important dans l'épidémie actuelle 
d'obésité et de troubles métaboliques. 
Des études faites sur des rats ont montré qu'une alimentation riche en sucre ou fructose 
induisait une obésité, une résistance à l'insuline, diabète, dyslipidémie et une hypertension 
artérielle, tandis que chez l'homme, une alimentation riche en fructose conduit, après quelques 
jours, au développement d'une hypertryglycémie et une résistance hépatique à l'insuline. 
Nous avons entrepris une étude de 7 jours d'alimentation riche en fructose ou d'une 
alimentation contrôlée chez six hommes en bonne santé. Les NEF A plasmatiques et la beta-
hydroxybutyrate, l'oxydation nette de lipide (calorimétrie indirecte) et l'oxydation exogène de 
lipide (13C02) ont été surveillés dans des conditions basales, et après un chargement en lipide 
(huile d'olive marqué au 13C-trioléine), puis durant un stress mental standardisé. La clearance 
de lactate et les effets métaboliques de la perfusion de lactate exogène ont également été 
évalués. 
Nos résultats ont montré que l'alimentation riche en fructose diminue la concentration 
plasmatique de NEF A, de beta-hydroxybutyrate de même que l'oxydation des lipides dans les 
conditions de bases et après surcharge en lipides. De plus, l'alimentation riche en fructose 
amortie l'augmentation des NEF A plasmatique et l'oxydation des lipides exogènes durant le 
stress mental. Elle augmente également la concentration basale de lactate et la production de 
lactate de respectivement 31.8% et 53.8%, tandis que la clearance du lactate reste inchangée. 
L'injection de lactate diminue le taux des NEFA lors de l'alimentation de contrôle et 
l'alimentation de base, et l'oxydation nette de lipide lors de l'alimentation de contrôle et 
l'alimentation riche en fructose. 
Ces résultats indiquent que 7 jours d'alimentation riche en fructose inhibent remarquablement 
la lipolyse et l'oxydation des lipides. L'alimentation riche en fructose augmente aussi la 
production de lactate, et l'augmentation de l'utilisation de lactate peut contribuer à supprimer 
l'oxydation des lipides. 
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The effects of a 7 d high-fructose diet (HFrD) or contrai diet on lipid metabolism were studied in a group of six healthy Jean males. Plasma NEFA 
and [3-hydroxybutyrate concentrations, net lipid oxidation (indirect calorimetry) and exogenous lipid oxidation (13C02 production) were monitored 
in basal conditions, after lipid loading (olive oil labelled with [1 3C]triolein) and during a standardised mental stress. Lactate clearance and the 
metabolic effects of an exogenous lactate infusion were also monitored. The HFrD lowered plasma concentrations of NEFA and [3-hydroxybuty-
rate as well as lipid oxidation in both basal and after lipid-loading conditions. In addition, the HFrD blunted the increase in plasma NEFA and 
exogenous lipid oxidation during mental stress. The HFrD also increased basal lactate concentrations by 31 ·8 %, and lactate production by 
53·8 %, while lactate clearance remained unchanged. Lactate infusion lowered plasma NEFA with the control diet, and net lipid oxidation with 
both the HFrD and control diet. These results indicate that a 7 d HFrD markedly inhibits lipolysis and lipid oxidation. The HFrD also increases 
lactate production, and the ensuing increased lactate utilisation may contribute to suppress lipid oxidation. 
High-fructose diets: Lipid metabolism: Lactate kinetics 
Consumption of fructose-containing sweetened beverages has 
increased markedly over the past decades, and is thought to 
play a significant role in the current epidemics of obesity 
and metabolic disorders0 ·2l. In rodents, high-sucrose or -fruc-
tose diets cause obesity, insulin resistance, diabetes mellitus, 
dyslipidaemia and high blood pressure<3l, while in humans, 
high-fructose hyperenergetic diets (HFrD) lead, over a few 
days, to the development of hypertriacylglycerolaemia and 
hepatic insulin resistance<4 - 3l. The metabolic effects of fruc-
tose have been widely studied, as reported in several recent 
reviews<9•10l; however, the mechanisms leading to fructose-
induced insulin resistance remain poorly understood. 
Several observations indicate that diet-induced insulin resis-
tance bears strong relationships with disturbances of intracellu-
lar lipid metabolism0 ll. An impaired capacity to oxidise lipids 
in skeletal muscle, and possibly in other tissues, is present in 
insulin-resistant individuals02•13l. Impaired fat oxidation may 
in turn lead to the accumulation of so-called 'ectopie' lipids, 
i.e. intracellular storage of T AG in non-adipose tissue cells, 
and oflipid metabolites, which may interfere with insulin signal-
ling and its actions<14l. It can therefore be suspected that inhi-
bition of lipid oxidation may participate in the adverse 
metabolic effects ofhigh-fructose diets. To evaluate this hypoth-
esis, we studied the effects of a 6-7 d HFrD on lipid metabolism, 
in a group of healthy young males. Whole-body net fat oxi-
dation, exogenous fat oxidation, adipose tissue lipolysis and 
Abbreviation: HFrD, high-fructose diet. 
plasma ketone body release were challenged by a lipid load 
that was followed by a mental stress, which stimulates sympath-
etic activity05l. Ali parameters were measured under fasting 
conditions, after lipid loading and after mental stress. Since an 
HFrD also causes a substantial rise in plasma lactate concen-
trations<6l, and increased lactate utilisation may in turn affect 
lipid metabolism06- 18\ we also studied lactate kinetics with 
[ 13C3]lactate infusion in the same subjects. 
Methods 
Subjects 
Six healthy young males (age 24·7 (so 3· 1) years; weight 78·3 
(so 7·4) kg; BMI 23· l (so 2·2) kg/m2) were recruited into the 
study. Ail were in good health, had no family history of type 2 
diabetes mellitus and were non-smokers. None took any medi-
cation at the time of inclusion or during the study. The experi-
mental protocol was approved by the ethical board of 
Lausanne University School of Biology and Medicine, and 
every subject provided informed, written consent. 
Dietary i11ten1ention 
Each subject was randomised to one of two diets: (1) a 7 d 
control diet calculated to provide his predicted energy 
*Corresponding author: Professor Luc Tappy, fax +41 21 692 55 95, email Luc.Tappy@unil.ch 
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requirements09l multiplied by a factor of 1·5 to account for 
the thermie effect of food and sedentary activity that was com-
posed of 55 % carbohydrate, 30 % fat and 15 % protein or (2) 
the same diet supplemented with 3·0 g fructose/kg body 
weight per d, corresponding to the fructose content of about 
4 litres sweetened beverage. This resulted in a mean extra 
fructose intake of 234 g and an excess energy intake of 
about 3640 kJ/d, resulting in an overall diet providing 67 % 
carbohydrate, 22 % fat and 11 % protein. The study was per-
formed on an out-patient basis, and fructose was provided as 
packs of fructose monohydrate to be dissolved in water and 
to be drunk in three divided doses with each main meal. A 
3-5-week wash-out period separated the two diets. We have 
observed in previous studies that a wash-out period of this dur-
ation is sufficient for complete return of metabolic parameters 
to baseline<6•7l. 
Metabolic study 1: lactate infusion 
On the morning of day 6 of each diet, subjects reported to the 
metabolic investigation unit at 07.00 hours after an overnight 
fast. Upon arrivai they were requested to void, after which 
their body weight was recorded. The subject was then comfor-
tably installed in a bed in a reclining position where they 
remained quietly watching television for the next 6 h. Two 
venous catheters were inserted, one into a forearm vein for 
infusion of [6,6-2H2]glucose (2 mg/kg bolus followed by 
20 µ,g/kg per min between time -120 to time 180min) and 
exogenous lactate (0·5 M-sodium lactate labelled with 0·05 % 
[ 13C3]lactate, infused at a rate of 20 mmol/kg per min between 
time 0 and 180 min), and the other into a wrist vein of 
the contralateral ann for blood collections. The hand on this 
side was maintained inside a thermostabilised box heated 
at 50°C to achieve arterialisation of venous blood. Respiratory 
gas exchange was measured continuously using a ventilated 
hood, open-circuit indirect calorimetry (Deltatrac II; Datex 
Instruments, Helsinki, Finland). Blood collections were 
obtained at tÎlne - 120 and every 30 min between - 30 and 
180 min for hormone and substrate measurements and for 
the determination of plasma [6,6-2H2]glucose enrichment. 
End-expiratory breath samples were collected every 30 min 
in vacutainers for determination of 13C02 enrichment. 
A timed urine collection was taken during the experiment to 
determine urea N excretion rate. 
Metabolic study 2: lipid loading and mental stress 
The present study took place on day 8 of each diet, and instru-
mentation procedures were the same as described for study 1. 
After 120 min of fasting measurements, three oral loads of 
10 g olive oil labelled with 100 mg [l- 13C3]triolein (Cam-
bridge Isotope Laboratory, Cambridge, MA, USA) were 
ingested at times 0, 60 and 120 min to measure exogenous 
fat oxidation<20J. A mental stress procedure, consisting of 
5 min periods of complex mental arithmetic alternated with 
5 min periods of Stroop's word colour conftict tests05l 
was a pp lied between 180 and 210 min. This procedure is 
known to activate the sympatho-adrenal axis and to produce 
stimulation of lipolysis<21 •22l. Blood collections were obtained 
at - 120 min and every 30 min from - 30 to 180 min, 
and subsequently at 190, 200, 210 and 240min for hormone 
and substrate measurements and for determination of plasma 
[6,6-2H2]glucose emichment. Saliva samples were obtained 
in basal conditions, after lipid loading and every 10 min 
during the 30 min mental stress test by using a saliva collec-
tion kit (Sarstedt AG, Sevelen, Switzerland). Expiratory 
breath samples were collected every 30 min in vacutainers 
for determination of 13C02 enrichment. 
A timed urine collection was performed during the experi-
ment to determine urea N excretion. 
Analytical procedures 
Plasma glucose was measured with the glucose oxidase 
method, using a Beckman Glucose Analyzer II (Beckman 
Instruments, Palo Alto, CA, USA). Plasma insulin and salivary 
cortisol concentrations were measured using RIA kits (Bio-
data, Guidoni, Montecello, Italy and DPC Inc., Los Angeles, 
CA, USA, respectively). Plasma NEFA were measured color-
imetrically using a kit from Wako (Freiburg, Germany). 
Plasma 13-hydroxybutyrate and TAG were measured enzymi-
cally using a kit from Boehringer (Mannheim, Germany). 
Plasma adrenaline and noradrenaline were measured by 
HPLc<23 l_ Plasma [6,6-2H2]glucose isotopie enrichment was 
measured with GC-MS, as described previousl/24•25 l. Breath 
13C02 isotopie enrichment was measured by isotope ratio 
MS on a Tracermass C/N (SerCon Ltd, Crewe, Cheshire, UK). 
Calculations 
All calculation procedures have been reported in detail else-
where. The rates of glucose appearance and disappearance 
were calculated from plasma [6,6-2H2]glucose isotopie enrich-
ment using Steele's equations for steady-state conditions<26i. 
Exogenous oleate<20l and lactate<27 l oxidations were calculated 
from 13C02 production. Whole-body net substrate oxidation 
rates were calculated using the equations of Livesey & 
Elia<23l_ During lactate infusion, it was assumed that lactate 
disappearance was equal to net lactate oxidation in order to 
calculate net glucose and lipid oxidation<27•29l. This net lactate 
oxidation may include oxidation of glucose synthesised from 
lactate. Lactate clearance was calculated using a 'pharmacoki-
netic' mode! from changes in plasma lactate concentrations 
during exogenous lactate infusion, and basal lactate pro-
duction was calculated as basal lactate concentration/lactate 
clearance <30l_ 
Statistical analysis 
All results in the text and tables are expressed as mean values 
with their standard errors. Comparisons between the control 
diet and the HFrD, or between fasting conditions, post-lipid 
conditions, and mental stress were done with the Wilcoxon 
signed rank test. 
Results 
Lipid metabolism in basal and after lipid-loading conditions is 
presented in Table 1 and illustrated in Fig. 1. 
In basal conditions, the HFrD, compared with the control 
diet, decreased plasma NEFA by 19·5 %, plasma 13-hydroxy-
butyrate by 78·2 % and whole-body lipid oxidation by 
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Table 1. Effects of a high-fructose diet (HFrD) on lipid and energy metabolism in basal conditions and alter lipid loading* 
(Mean values with their standard errors) 
Contrai HFrD 
Basal Lipid loading Basal Lipid loading 
Mean SEM Mean SEM Mean SEM Mean SEM 
Plasma glucose (mmol/I) 4·6 0·1 4.3 0·2 4.5 0·1 4.5 0·1 
Plasma NEFA (mmol/I) 0-41 0·09 0-45 0·05 0·33t 0·08 0·41 0·06 
Plasma TAG (mmol/I) 0·49 0·05 0·67 0·11 0·81t 0·18 1·00t 0·20 
Plasma {3-hydroxybutyrate (mmol/I) 55 17 13t 3 
Energy expenditure (kJ/kg per min) 0·057 0·005 0·057 0·004 0·057 0·005 0·057 0·005 
Carbohydrate oxidation (mg/kg per min) 1·24 0·19 0·92 0·14 1·99t 0·19 1·62t 0·17 
Lipid oxidation (mg/kg per min) 0·71 0·11 0·89 0·10 0-49t 0·10 0·73t 0·05 
Exogenous lipid oxidation 27 3 24 1 
•Basal conditions: blood samples were obtained in the lasting state, with a rest period of 120 min after instrumentation of the subject. Lipid loading: 
blood samples were collected 150 and 180min alter lipid loading, and the values obtained were averaged for presentation. 
t Mean value was significantly different from that of contrai (P< 0·05). 
21·3 % (all P<0·05; Table 1). After lipid loading, there was 
no significant change in plasma glucose, insulin or NEFA con-
centrations in either condition but plasma 13-hydroxybutyrate 
increased (P< 0·05) in both conditions, although it tended to 
be lower with the HFrD (P=0· 12; Fig. 1). Whole-body net 
lipid oxidation increased slightly by 0· 18 mg/kg per min 
with the control diet and by O· 24 mg/kg per min with the 
HFrD (NS). Absolute levels of lipid oxidation remained 
lower (P< 0·05) on the HFrD than with the control diet 
(Table 1). Breath 13C02 isotopie enrichment and oxidation 
of exogenous lipids (Table 1) over the first 3 h after lipid load-
ing were comparable between the HFrD and control diet. 
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Lipid metabolism during mental stress 
During mental stress, plasma cortisol, adrenaline and nor-
adrenaline concentrations increased to the same extent with 
the HFrD and with the control diet (Table 2), while glucose 
and insulin concentrations remained unchanged (Fig. 1). 
Plasma NEFA increased significantly during mental stress, 
but the integrated incremental area under the curve was sig-
nificantly Jower with the HFrD (P< 0·03) than with the control 
diet (Fig. 1). The concentration of 13-hydroxybutyrate did not 
change during mental stress, and tended to be lower with the 
HFrD than with the control diet (P=0·12; Fig. 1). During the 
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Fig. 1. Changes in (A) plasma glucose, (B) insulin, (C) NEFA and (D) {3-hydroxybutyrate concentrations during lipid loading and during mental stress (MS). Values 
are means, with standard errors represented by vertical bars. (0), High-fructose diet; (+), control conditions; ! , limes at which olive oil was ingested. •Mean 
values were significantly different (P<D·D5). 
z 
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Table 2. Effects of a high-fructose diet (HFrD) on lipid and energy metabolism during mental stress 
(Mean values with their standard errors) 
Contrai HFrD 
Mean SEM Mean SEM 
Base li ne* 
Glucose (mmol/I) 4.3 0·2 4.7 0·2 
NEFA (mmol/I) 0·41 0·06 0-46 0·05 
Adrenaline (pg/ml) 47 7 46 13 
Noradrenaline (pg/ml) 130 55 135 65 
Salivary cortisol (nmol/I) 4·1 OA 4·6 0·2 
lncremental areas under the curve 
alter mental stress 
Glucose (mmol/I x 30 min) 16 25 -9 8 
NEFA (mmol/I x 30 min) 8·0 2·2 3·8t 2-4 
Adrenaline (pg/ml x 30 min) 689 235 620 346 
Noradrenaline (pg/ml x 30 min) 2783 562 2746 850 
Salivary cortisol (nmol/I x 30 min) 11-4 5.3 32 23 
Exogenous lipid oxidation alter mental 15 2 11t 2 
stress (mg/kg per h) 
*Basal conditions: blood samples were obtained immediately before mental stress, i.e. 180 min alter the beginning of the lipid loading. 
t Mean value was significantly different from that of contrai (P<0·05). 
60 min period between 180 and 240 min, which corresponded 
to the 30 min mental stress + 30 min recovery, breath 13C02 
and exogenous lipid oxidation increased with both the HFrD 
and contrai diet, but were significantly lower after the HFrD 
(P<0·05; Table !). 
Lactate metabolism 
Basal lactate production increased by 52·4 % while on the 
HFrD (P< 0·001 ). At the end of the dietary periods basal lac-
tate concentrations were 33·2 % higher with the HFrD than 
with the contra] diet (P<O·Ol) (Table 3 and Fig. 2), but the 
increment in plasma lactate (Fig. 2), and hence calculated lac-
tate clearance (Table 3), were comparable between the two 
conditions. Calculated basal lactate production was signifi-
cantly higher while on the HFrD. 
Exogenous lactate infusion did not change glucose rate of 
appearance or plasma glucose concentrations (Table 3). 
Plasma NEF A tended to be decreased ( - 15 % ; P= 0· 12) 
after the contra! diet, but not after the HFrD (Fig. 2 and 
Table 3). Lactate infusion decreased net whole-body lipid oxi-
dation by 30·7 % with the contra! diet (P< 0·02) and 34· l % 
with the HFrD (P<O·Ol; Table 3). Breath 13C02 isotopie 
enrichment increased similarly after the HFrD and contrai 
diet and exogenous lactate oxidation was similar under both 
conditions (8·0 (SEM 0·4) µ,mol/kg per min after the contra! 
diet v. 8·7 (SEM 0·5) µ,mol/kg per min after the HFrD; NS). 
Discussion 
The present results demonstrate than a 7 d HFrD has important 
effects on lipid metabolism and oxidation in healthy human 
subjects and caused a significant (P<0·05) increase in fasting 
plasma TAG concentrations<4•6•7•3 1). Although compliance to 
fructose supplementation was not directly assessed, the con-
sistency of this observation with previous reports<4•6•7•9 •31 l 
Table 3. Effects of a high-fructose diet (HFrD) on energy and substrate metabolism in basal conditions and alter lactate infusion 
(Mean values with their standard errors) 
Contrai HFrD 
Basal Lactate Basal Lactate 
Mean SEM Mean SEM Mean SEM Mean SEM 
Plasma glucose (mmol/1) 4·8 0·1 4.9 0·1 5·1 0·2 5·0 0·2 
Plasma NEFA (mmol/I) 0·60 0·07 0·52 0·04 0·36* 0·09 0·39* 0·09 
Plasma lactate (mmol/I) 0·85 0·05 2·50t 0·09 1·12 0·17 2·75t 0·14 
Lactate clearance (ml/min) 12 1 13 2 
Lactate production (µmol/kg per min) 10-4 1·2 16·0* 5.3 
Glucose rate of appearance (µmol/kg per min) 11-5 0·5 10-4 0·5 11·8 0·5 10·3 0·5 
Energy expenditure (kJ/kg per min) 0·057 0·005 0·062 0·005 0·054 0·005 0·057 0·004 
Carbohydrate oxidation (mg/kg per min) 1·36 0·11 0·65t 0·19 1·95* 0·24 0·85•t 0·25 
Lipid oxidation (mg/min) 0·65 0·06 OA5t 0·11 0-41* 0·07 o.27·t 0·09 
Lactate oxidation (µmol/kg per min) 0 0 20 0 0 0 20 0 
*Mean value was significantly different from that of contrai (P<0·05). 
t Mean value was significantly different from that in basal conditions (P< 0·05). 
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Fig. 2. Changes in (A) plasma glucose, (B) insulin, (C) NEFA and (D) lactate concentrations during exogenous lactate infusion. Values are means, with standard 
errors represented by vertical bars. (0), High-fructose diet; (+), control conditions.* Mean values were significantly different (P<0·05). 
provides indirect evidence that the bulk of the supplementary 
fructose prescribed to the participants was indeed consumed. 
Besides this well-known increase in plasma T AG concen-
trations, the HFrD significantly inhibited several pathways of 
lipid catabolism. In basal conditions, the HFrD significantly 
decreased plasma NEFA concentrations, net lipid oxidation 
and plasma [3-hydroxybutyrate concentrations. After lipid 
loading, the increase in net lipid oxidation and exogenous 
lipid oxidation were comparable after the HFrD and contrai 
diet, but mental stress markedly blunted the stimulation of 
plasma NEFA and [3-hydroxybutyrate release. Whole-body 
net lipid oxidation could not be calculated during mental 
stress, because the significant degree of hyperventilation 
which occurs dming this procedure precludes the accurate 
calculation of the RER(15). Exogenous lipid oxidation 
could, however, still be calculated since this procedure is 
Jess sensitive to small inaccuracies in the measurement of 
C02 productionC32l, and was also significantly inhibited after 
the HFrD. 
The lower basal plasma NEFA concentrations, and the 
blunted response of NEFA to mental stress, indicate an inhi-
bition of adipose tissue lipolysis after the HFrD. Under such 
conditions, HFrD-induced hypertriacylglycerolaemia is unli-
kely to be secondary to an increased hepatic re-estedfication, 
and is likely to be related to fructose-induced stimulation of 
hepatic de novo lipogenesis. However, the inhibition of lipoly-
sis may in turn be directly responsible for lower whole-body 
net lipid oxidation and plasma [3-hydroxybutyrate concen-
trations, since NEFA concentrations are the main determinant 
of these processes. Alternatively, a direct inhibition of hepatic 
[3-oxidation and ketogenesis may also be involved. Rats 
prone to develop diet-induced obesity exhibit similar altera-
tions to those observed in human subjects after the HFrD, 
i.e. decreased basal whole-body and hepatic lipid oxidation 
and blunted stimulation of ketone body release. These effects 
were associated with decreased hepatic expression of genes 
involved in lipid transport and oxidationC33l. Fructose, by 
exerting a direct effect on liver metabolism, is likely to act 
on similar pathways. In support of this hypothesis, it has 
been reported that an HFrD, but nota high-glucose diet, mark-
edly reduces hepatic [3-oxidation in rats through inhibition of 
the expression of PPARa-dependent genesc34l, 
Intriguingly, these effects of the HFrD on lipid metabolism 
were observed in the absence of significant changes in 
plasma insulin, and with only minimal changes in plasma glu-
cose, suggesting that a change in insulin secretion is not pri-
marily involved. The HFrD therefore lowered plasma NEFA 
presumably through inhibition of lipolysis. The mediator(s) 
responsible for this effect remain speculative at this point. 
Changes in plasma concentrations of key metabolic substrates 
appear to be prime candidates. As already reported in several 
studiesc35•36l, an HFrD increases basal lactate concentrations. 
Our present results, collected during an exogenous lactate 
infusion, indicate that lactate clearance was essentially 
unchanged after the HFrD, and hence the observed increase 
in lactate concentration can be attributed to an increased lac-
tate production. The results of the present experiment do not 
allow us to identify the sites of lactate production. The 
increased lactate production was matched by increased lactate 
utilisation at the whole-body level, and it is reasonable to 
assume that part of it was oxidised in adipose tissue and skel-
etal muscle. We further propose the hypothesis that increased 
muscle lactate uptake partially replaced lipid as an energy sub-
strate and hence contributed to inhibit lipid oxidation. 
Our observation of suppressed whole-body net lipid 
oxidation after lactate infusion is certainly consistent with 
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this hypothesis. Furthermore, we propose that increased lactate 
metabolism in adipose tissue may contribute to the inhibition 
of adipose tissue lipolysis. In support of this hypothesis, 
exogenous lactate infusion significantly lowered plasma 
NEFA in subjects fed the control diet. Lactate infusion, how-
ever, failed to further suppress plasma NEFA after the HFrD, 
possibly because increased adipose lactate metabolism was 
already maximally effective under such conditions. 
The present study has several limitations that have to be 
acknowledged. First, compliance to the diet and fructose 
supplementation could not be directly assessed; however, the 
HFrD did cause the expected increase in plasma T AG concen-
trations, which indicates that the bulk of the fructose sup-
plement had been ingested as prescribed. Tt remains, 
however, possible that fructose supplementation led to 
changes in fat, protein and non-fructose carbohydrate intake. 
Second, the HFrD provided excess fructose, total carbohydrate 
and energy intake. Although it is possible to speculate, based 
on previous reports showing an acute suppression of NEFA 
and a marked increase in lactate concentrations after fructose 
ingestionc35 - 37>, that the observed inhibition of plasma NEFA 
was essentially linked to fructose intake, one cannot exclude 
that similar effects would be produced by glucose or fat over-
feeding as well. Third, the volunteers of the present study 
were submitted to supplementation with a large fructose 
Joad, which largely exceeds usual fructose intake<38·39l. Such 
high sugar intakes may, however, be occasionally encountered 
in clinical practice. The present data nonetheless indicate that 
a very high fructose intake causes significant changes in adi-
pose tissue lipolysis, and hence that fructose intake is likely 
to modulate the fonctions of adipocytes. Our previous obser-
vation, that ove1feeding with half the dose of fructose as 
used in the present study led to a significant decrease in fasting 
plasma NEFA concentrations(?), suggests that such an 
effect may also be present with lower, more usual fructose 
intake. Fourth, the 7 d HFrD failed to induce a significant 
whole-body insulin resistance in these healthy volunteers, as 
previously reportedc6·7l. This contrasts with animal studies 
showing that an HFrD leads to an important reduction of insu-
lin sensitivity, or even to overt diabetes mellitus (for a review, 
see Bizeau & Pagliassotti<40l). Higher fructose intakes in 
animal studies may explain part of these differences. The dur-
ation of fructose overfeeding may also be a crucial factor, 
since insulin resistance was observed after several weeks of 
an HFrD in rodents. And finally, the calculation of exogenous 
lipid oxidation rests on the measurements of breath 13C02, 
which increases with an important lag time. After lipid load-
ing, the breath 13C02 curve obtained after the HFrD and 
after the control diet started to dissociate during hour 3 of 
lipid loading, but the difference became significant only 
during hour 4, i.e. dming mental stress. We cannot, however, 
unequivocally attribute this difference to fructose-induced 
alterations of the metabolic responses to stress, since it may 
merely represent a carry-over effect of lipid loading. This 
difference nonetheless indicates that the HFrD significantly 
inhibited exogenous lipid oxidation, be it lower utilisation of 
exogenous lipids or impaired stimulation by mental stress. 
In summary, the present results indicate that, in healthy 
human subjects, a 7 d supplementation with a large amount 
of fructose decreases whole-body lipid oxidation and hepatic 
ketogenesis. These effects, if present with lower, more 
usual, fructose intakes, may, in the long term, play an import-
ant role in the development of fructose-induced metabolic dis-
orders. Tt has indeed been reported, in an animal mode!, that 
fructose-induced inhibition of hepatic lipid oxidation was 
directly linked to hepatic fat accumulation and hypertriacyl-
glycerolaemia<341. An HFrD also stimulates lactate production, 
and the ensuing increase in extrahepatic lactate metabolism 
may contribute to impair lipid mobilisation and oxidation. 
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